Anti-TNFα therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other diseases

Transplantation Proceedings

Volumn 30, Issue 8, 1998, Pages 4126-4127

  Feldman, M ^a   Taylor, P ^a   Paleolog, E ^a   Brennan, F M ^a   Maini, R N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CD4 ANTIGEN; CHEMOKINE; CHIMERIC ANTIBODY; CYTOKINE; ETANERCEPT; INTERLEUKIN 1; INTERLEUKIN 6; REMICAIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; EXPERIMENTAL MODEL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CROHN DISEASE; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032413352     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01365-7     Document Type: Conference Paper

References (9)

1. 1. Brennan FM, Chantry D, Jackson A, et al: Lancet 2:244, 1989
2. 2. Brennan FM, Maini RN, Feldmann M: Br J Rheumatol 31:293, 1992
3. 3. Rankin ECC, Choy EHS, Kassimos D, et al: Br J Rheumatol 34:334, 1995
4. 4. Moreland LW, Baumgartner SW, Schiff MH, et al: Engl J Med 337:141, 1997
5. 5. Feldmann M, Elliott MJ, Woody JN, et al: Immunol 64:283, 1997
6. 6. Feldmann M, Brennan FM, Maini RN: Ann Rev Immunol 14:397, 1996
7. 7. Scallon BJ, More MA, Trinh H, et al: Cytokine 7:251, 1995
8. 8. Paleolog EM, Young S, Stark AC, et al: Arth Rheum 41:1258, 1998)
9. 9. Williams RO, Mason LJ, Feldmann M, et al: Proc Natl Acad Sci USA 91:2762, 1994